Previous Close | 2.9800 |
Open | 2.9500 |
Bid | 3.0500 x 900 |
Ask | 3.0600 x 1300 |
Day's Range | 2.9250 - 3.1150 |
52 Week Range | 1.7000 - 4.0300 |
Volume | |
Avg. Volume | 354,160 |
Market Cap | 287.432M |
Beta (5Y Monthly) | 1.50 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Shares of Accuray (NASDAQ: ARAY) were up as much as 17.6% on Thursday. The medical instruments maker, which specializes in radiation oncology machines, released its fiscal 2023 second-quarter earnings report late Wednesday. In the second-quarter report, CEO Suzanne Winter said the company set a record with 29 new systems delivered.
Despite solid product demand, Accuray (ARAY) reports an overall soft fiscal Q2 performance.
Accuray (ARAY) delivered earnings and revenue surprises of 33.33% and 7.98%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?